bmc and bmbc/cu mm bm were monitored in 16 patients with acute nonlymphoblastic leukemia treated with daunorubicin , cytosine arabinoside , and 6-thioguanine in combination and in 4 patients with end-stage acute leukemias and non-hodgkin 's lymphomas during high-dose thymidine therapy .
C0023467
acute nonlymphoblastic
C0011015
daunorubicin